MedPath

Comparison of Total Knee Arthroplasties With Oxidized Zirconium and Cobalt Chromium Femoral Components

Phase 4
Completed
Conditions
Osteoarthritis
Interventions
Device: Zirconium (Zirconium Genesis II)
Device: Cobalt-Chrome (Cobalt Chrome Genesis II)
Registration Number
NCT01336595
Lead Sponsor
Ewha Womans University
Brief Summary

The purpose of this study is to determine if there are any clinical or radiographic differences in cemented total knee arthroplasty with an oxidized zirconium and a cobalt-chromium femoral knee component.

Detailed Description

Although it has been claimed that total knee arthroplasties with an oxidized zirconium femoral knee component had beneficial wear properties in vitro, there are conflicting clinical results. The purpose of the present study was to compare the clinical, subjective, and radiographic results as well as the weight, size and shape of polyethylene wear particles in the patients with an oxidized zirconium and a cobalt-chromium femoral knee component.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
331
Inclusion Criteria
  • End-stage osteoarthritis of the knee joint requiring total knee arthroplasty with bilateral disease
Exclusion Criteria
  • Inflammatory disease
  • patient with other Lower extremity disease which may affect functional outcome
  • Neurologic disease effecting patients lower extremity
  • Revision surgery
  • Patient not medically cleared for bilateral surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Zirconium Femoral ComponentZirconium (Zirconium Genesis II)Oxidized zirconium femoral component of Genesis II TKR system is used.
Cobalt ChromeCobalt-Chrome (Cobalt Chrome Genesis II)Cobalt-Chromium Femoral component of Genesis II system is used.
Primary Outcome Measures
NameTimeMethod
Improvement in Knee Society Knee ScoreInitial(one day before surgery), and at 3 months, 1 year, then annually after surgery

change in knee score will be compared with initial score, until mean follow up of 20 years.

Secondary Outcome Measures
NameTimeMethod
Improvement in the range of motionInitial(one day before surgery), and at 3 months, 1 year, then annually after surgery

change in the range of motion of knee joint will be compared with the initial value, until mean follow up of 20 years.

Trial Locations

Locations (1)

Ewha Womans University Mokdong Hosptial

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath